Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

DYN.US Logo

DYN.US - Current Price

$17.46

Company Information

â–Ľ
Company Name
Dyne Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US26818M1080
CIK: 0001379895
CUSIP: 26817G300
Currency: USD
Full Time Employees: 240
Phone: 781 786 8230
Website: https://www.dyne-tx.com
Fiscal Year End: December
IPO Date: Sep 17, 2020
Description:

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Address:

1560 Trapelo Road, Waltham, MA, United States, 02451

Directors & Officers

â–Ľ
Name Title Year Born
Mr. John G. Cox M.B.A. CEO, President & Director 1963
Dr. Oxana Beskrovnaya Ph.D. Chief Innovation Officer 1961
Ms. Johanna Friedl-Naderer Chief Commercial Officer 1968
Dr. Douglas Kerr M.B.A., M.D., Ph.D. Chief Medical Officer 1967
Mr. Erick J. Lucera C.F.A., CPA CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer 1968
Dr. Axel Wiest Senior VP and Head of Portfolio Strategy & Operations NA
Dr. Rajesh Manchanda Ph.D. Chief Technical Officer 1966
Mr. James P. Bilotta M.B.A. Chief Digital & Information Officer NA
Dr. Ranjan Batra Ph.D. Chief Scientific Officer NA
Mr. Daniel Wilson Senior VP & Head of Legal 1972

Shares Statistics

â–Ľ
Shares Outstanding: 164.65M
Shares Float: 134.21M
% Insiders: 43.60%
% Institutions: 10,775.60%
Short % Float: 9.98%

Valuation Metrics

â–Ľ
Enterprise Value: $2.25B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

â–Ľ
Market Cap: $2.87B
EBITDA: $-447.18M
PEG Ratio: $0.19
Book Value: $4.85
Earnings/Share: $-3.56
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -34.32%
ROE (TTM): -60.66%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

â–Ľ

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

â–Ľ

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

â–Ľ
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 -0.78 N/A 10,000.00%
Sep 30, 2025 -0.76 -0.84 N/A 952.38%
Jun 30, 2025 -0.97 -0.94 N/A -319.15%
Mar 31, 2025 -1.05 -0.84 N/A -2,553.80%
Dec 31, 2024 -0.88 -0.91 N/A 350.88%
Sep 30, 2024 -0.96 -0.71 N/A -3,560.56%
Jun 30, 2024 -0.70 -0.72 N/A 277.78%
Mar 31, 2024 -0.81 -0.80 N/A -125.00%
Dec 31, 2023 -1.09 -0.92 N/A -1,847.83%
Sep 30, 2023 -0.99 -0.83 N/A -1,927.71%
Jun 30, 2023 -1.08 -0.81 N/A -3,333.33%
Mar 31, 2023 -0.78 -0.77 N/A -129.87%
Dec 31, 2022 -0.74 -0.84 N/A 1,190.48%
Sep 30, 2022 -0.80 -0.92 N/A 1,304.35%
Jun 30, 2022 -1.01 -0.77 N/A -3,116.88%
Mar 31, 2022 -0.69 -0.88 N/A 2,159.09%
Dec 31, 2021 -1.00 -0.99 N/A -101.01%
Sep 30, 2021 -0.83 -0.64 N/A -2,968.75%
Jun 30, 2021 -0.58 -0.55 N/A -545.45%
Mar 31, 2021 -0.50 -0.60 N/A 1,666.67%
Dec 31, 2020 -0.64 -0.37 N/A -7,297.30%
Sep 30, 2020 -2.01 -0.87 N/A -13,103.45%
Jun 30, 2020 -0.39 0.00 N/A N/A
Dec 31, 2017 -0.35 -0.42 N/A 1,666.67%
Sep 30, 2017 0.31 0.55 N/A -4,363.64%
Jun 30, 2017 -1.12 -0.71 N/A -5,774.65%
Mar 31, 2017 -1.24 -0.11 N/A -102,727.27%
Dec 31, 2016 -1.40 0.14 N/A -110,000.00%
Sep 30, 2016 -0.30 0.21 N/A -24,285.71%
Jun 30, 2016 -1.36 -0.69 N/A -9,710.14%

Balance Sheet (Yearly)

â–Ľ
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $435.45M $N/A $691.23M $61.40M $629.84M
2023-12-31 $121.63M $N/A $165.08M $73.79M $91.29M
2022-12-31 $172.15M $N/A $306.33M $53.96M $252.36M
2021-12-31 $200.83M $N/A $425.66M $57.47M $368.20M
2020-12-31 $300.85M $N/A $353.33M $10.97M $342.37M
2019-12-31 $14.63M $N/A $16.44M $2.40M $14.04M
2018-12-31 $8.12M $N/A $8.27M $13.15M $-4.88M
2017-12-31 $365.00M $N/A $11.77B $9.87B $1.90B
2016-12-31 $1.78B $N/A $13.05B $11.01B $2.04B
2015-12-31 $505.00M $N/A $11.54B $8.62B $2.92B
2014-12-31 $1.87B $N/A $11.23B $8.21B $3.02B
2013-12-31 $843.00M $N/A $5.29B $3.08B $2.21B
2012-12-31 $348.00M $N/A $4.54B $2.03B $2.50B
2011-12-31 $396.00M $N/A $4.13B $3.02B $1.11B
2010-12-31 $291.00M $N/A $10.01B $7.27B $2.75B
2009-12-31 $471.00M $N/A $10.95B $7.97B $2.90B
2008-12-31 $693.00M $N/A $14.21B $9.73B $4.52B
2007-12-31 $328.00M $N/A $13.22B $8.69B $4.51B

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 05, 2025 N/A N/A N/A N/A N/A N/A
Jul 14, 2025 N/A N/A N/A N/A N/A N/A
Mar 13, 2025 N/A N/A N/A N/A N/A N/A
Mar 11, 2025 N/A N/A N/A N/A N/A N/A
Mar 11, 2025 N/A N/A N/A N/A N/A N/A
Feb 18, 2025 N/A N/A N/A N/A N/A N/A
Dec 11, 2024 N/A N/A N/A N/A N/A N/A
Dec 11, 2024 N/A N/A N/A N/A N/A N/A
Nov 18, 2024 N/A N/A N/A N/A N/A N/A
Nov 14, 2024 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist